Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · ANURAS

ANURAS

CommoditiesChemicals & Petrochemicals₹15009 cr market cap
₹1327.00 ▲ +0.45% today As of 19 Nov 2026
52-week low ₹1071.8052-week high ₹1376.00

-4.0% from the 52-week high · +23.3% above the low

Anupam Rasayan India Ltd. manufactures pharmaceutical and specialty chemical products. The company is headquartered in Surat, Gujarat. The company went IPO on 2021-03-24. The Company’s segments include Life Science Related Specialty Chemicals and Other Specialty Chemicals. The company manufactures a variety of life science related specialty chemicals comprising products related to agrochemicals, personal care, and pharmaceuticals. The firm manufactures agro intermediates and agro active ingredients for the agrochemicals industry, which are used in the manufacture of, amongst others, insecticides, fungicides, and herbicides. For the personal care industry, it provides, amongst others, anti-bacterial and ultraviolet protection intermediates, and ingredients. In the pharmaceutical segment, the Company focuses on developing intermediates and key starting materials for active pharmaceutical ingredients. The Company’s other specialty chemicals are used in diverse end-user segments, comprising specialty pigments, specialty dyes and polymer additives.

The short version. ANURAS reported revenue of ₹806 crore for Sep 2026, up 10.3% from a year earlier. Net profit was ₹50 crore (up 13.6% year on year). Return on equity was 5.1% in Mar 2026. Promoter holding was 59.07% in Sep 2026, down 2.11 points over 8 quarters.

1 · The price

How has the stock traded?

ANURAS trades 4.0% below its 52-week high and 23.3% above its 52-week low.

Change over period: —

1M+19.1%
3M+7.8%
6M-3.7%
1Y+19.4%

2 · The business

Is it growing?

Sales, year on year+10.3%

Sep 2026 revenue of ₹806 cr.

Profit, year on year+13.6%

Sep 2026 net profit of ₹50 cr.

Net margin6.2%

0.1 pts higher than a year earlier.

3-year growth-2.0% profit

Revenue compounded at 14.0% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue806655636512731486500390
Net profit5039434944344528
Net margin %6.25.96.79.66.17.08.97.2
EPS (₹)4.393.393.754.313.93.14.052.56

Annual

FY2026FY2025FY2024FY2023FY2022FY2021
Revenue23651437147516021066811
Net profit1709312918115270
Net margin %7.26.58.711.314.38.7
EPS (₹)14.948.4911.7116.8315.187.04

3 · The quality

How well does it turn capital into profit?

Return on equity was 5.1% in Mar 2026; debt to equity is 0.54.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %5.13.34.77.6
Return on capital %7.59.010.112.4
EBITDA margin %22.828.527.327.3
Net margin %7.16.48.511.2

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR14.0%23.3%
Profit CAGR-2.0%19.3%
Debt to equity0.54
Interest cover2.7x
Current ratio1.43
P/E ratio72.4

4 · The owners

Who holds it, and are they adding?

Promoter holding59.07%

Down 2.11 pts over 8 quarters.

Foreign institutions8.66%

Up 1.21 pts over 8 quarters.

Domestic institutions2.27%

Down 0.05 pts over 8 quarters.

Mutual fund schemes41

+9 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter61.1861.1861.1859.0759.0759.0759.0759.07-2.11
FII7.456.464.947.637.66.917.718.66+1.21
DII2.322.252.241.370.420.350.382.27-0.05
Public29.0530.1131.6531.9232.933.6732.8330.01+0.96

Mutual fund holdings · Oct 2026

41 schemes hold this stock

32 the month before.

  • ITI Mid Cap Fund1.6% of NAV
  • ITI ELSS Tax Saver Fund1.3% of NAV
  • Nippon India Nifty 500 Equal Weight Index Fund0.21% of NAV
  • Groww Nifty Smallcap 250 Index Fund0.16% of NAV
  • JioBlackRock Nifty Smallcap 250 Index Fund0.16% of NAV
  • Groww Nifty Smallcap 250 ETF0.16% of NAV
  • ICICI Prudential Nifty Smallcap 250 Index Fund0.16% of NAV
  • Mirae Asset Nifty Smallcap 250 ETF0.16% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for ANURAS are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about ANURAS

What is the ANURAS share price?

ANURAS (ANURAS) last closed at ₹1,327.00, up 0.45% on the day. Its 52-week range is ₹1,071.80 to ₹1,376.00.

What is the market cap of ANURAS?

ANURAS has a market capitalisation of about ₹15,009 crore. Its price-to-earnings ratio is 72.4.

How are ANURAS's latest results?

ANURAS reported revenue of ₹806 crore for Sep 2026, up 10.3% from a year earlier. Net profit was ₹50 crore (up 13.6% year on year). Return on equity was 5.1% in Mar 2026. Promoter holding was 59.07% in Sep 2026, down 2.11 points over 8 quarters.

Who owns ANURAS?

As of Sep 2026, shareholding was: Promoter 59.07%, FII 8.66%, DII 2.27%, Public 30.01%.

How many mutual funds hold ANURAS?

41 mutual fund schemes held ANURAS in October 2026. That compares with 32 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 21 Jul 2025 · Interim Dividend - Rs. 0.75
  • 17 Sep 2024 · Final Dividend - Rs. 0.75
  • 20 Nov 2023 · Interim Dividend - Rs. 0.5
  • 15 May 2023 · Interim Dividend - Rs. 1.5
  • 08 Feb 2023 · Interim Dividend - Rs. 0.6
  • 02 Sep 2022 · Final Dividend - Rs. 1

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.